ArticleBrazilian journal of veterinary medicine2026
Cardiovascular evaluation in overweight and obese dogs.
Article in Brazilian journal of veterinary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canine obesity is a multifactorial nutritional disorder characterized by excessive accumulation of adipose tissue with systemic health consequences. However, the cardiovascular effects of obesity in dogs have not been completely characterized. This study aimed to evaluate the clinical, electrocardiographic, and echocardiographic parameters of dogs with normal body condition, overweight, and obesity. Thirty client-owned dogs were divided into three groups of ten: Group 1 (G1, body condition score [BCS] 4-5/9), Group 2 (G2, overweight, BCS 6-7/9), and Group 3 (G3, obese, BCS 8-9/9). All animals underwent physical examination, electrocardiography, and echocardiography, and their canine body mass index and thoracic-to-abdominal circumference ratio were measured. Exercise intolerance and dyspnea were significantly more frequent in G3 (90% and 70%) than in G1 (20% and 10%) and G2 (60% and 10%) (p<0.05). The P-wave (p = 0.030) and QRS (p = 0.049) durations increased progressively from G1 to G3. The left atrial diameter (p = 0.010) and left atrium-to-aortic root ratio (p = 0.011) were significantly greater for G3, and mitral valve abnormalities were more prevalent in obese dogs (p = 0.023). The thoracic-to-abdominal circumference ratio was significantly lower in G2 and G3 (p = 0.003), reflecting abdominal fat redistribution. No significant differences were found in the systolic or conventional diastolic function indices. These findings indicate that obesity in dogs is associated with early cardiovascular alterations, morphometric changes, electrocardiographic conduction delays, and left atrial remodeling in the absence of overt cardiac dysfunction. This underscores the importance of routine cardiovascular monitoring in overweight and obese canine patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.